Several South American countries report coronavirus disease cases in select areas since late February. Maintain basic health precautions.

Severity: Informational Alert

The locations affected by this alert are:

  • Argentina
  • Brazil
  • Chile
  • Colombia
  • Ecuador
  • Peru

This alert began 09 Mar 2020 13:45 GMT and is scheduled to expire 31 Mar 2020 23:59 GMT.

  • Incident: Imported cases of coronavirus disease (COVID-19)
  • Location(s): Select locations in Argentina, Brazil, Chile, Colombia, Ecuador, and Peru (map)
  • Period: February-March 2020

Several South American countries have identified imported cases of coronavirus disease (COVID-19). Test results are pending in additional suspected cases, some of which will likely be confirmed. As of March 9, confirmed cases were reported in the following areas:

  • Argentina: 1 case in Buenos Aires
  • Brazil: 2 cases in Sao Paulo
  • Chile: 1 case San Javier, Maule Region
  • Colombia: 1 case Bogota
  • Ecuador: 7 cases in Guayaquil
  • Peru: 6 cases Lima and Arequipa

Background and Analysis
Health authorities expect imported cases of COVID-19 as disease surveillance continues globally. Older individuals, infants, and those with chronic illness are more susceptible to infection and are at increased risk for severe complications. Human-to-human transmission is occurring, though it remains unclear how easily the virus spreads between people.

Emphasize basic health precautions, especially frequent handwashing with soap and water, or an alcohol-based hand sanitizer if soap and water are unavailable. Practice good coughing/sneezing etiquette (i.e., covering coughs and sneezes with a disposable tissue, maintaining distance from others, and washing hands). There is no evidence that the influenza vaccine, antibiotics, or antiviral medications will prevent this disease, highlighting the importance of diligent basic health precautions.

WHO advice for international travel

WHO coronavirus knowledge base

US CDC Guidance for Businesses and Employers


Return to SARS-CoV-2 and COVID-19 Intelligence Center >>